Lurasidone use while Breastfeeding

Drugs containing Lurasidone: Latuda

Lurasidone Levels and Effects while Breastfeeding

Summary of Use during Lactation

Because there is no published experience with lurasidone during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Lurasidone has caused elevated prolactin serum in patients taking the drug.[1] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.

Alternate Drugs to Consider

Haloperidol, Olanzapine, Risperidone

References

1. Anon. Latuda package insert. Sunovion Pharmaceuticals Inc. Ft. Lee, NJ. 2010.

Lurasidone Identification

Substance Name

Lurasidone

CAS Registry Number

367514-87-2

Drug Class

Antipsychotic Agents

Administrative Information

LactMed Record Number

821

Last Revision Date

20130907

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.

Hide
(web3)